A clinical and pathomechanistic profile of chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis and challenges facing the field

References

• Ferguson PJ, El-Shanti HI. Autoinflammatory bone disorders. Curr. Opin. Rheumatol. 19, 492 (2007).
   PubMed Web of Science ®Google Scholar
• Girschick HJ, Zimmer C, Klaus G, Darge K, Dick A, Morbach H. Chronic recurrent multifocal osteomyelitis: what is it and how should it be treated? Nat. Clin. Pract. Rheumatol. 3, 733 (2007).
   PubMedGoogle Scholar
• Hofmann SR, Roesen-Wolff A, Hahn G, Hedrich CM. Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO). Int. J. Rheumatol. 2012, 310206 (2012).
   Google Scholar
• Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu. Rev. Immunol. 27, 621 (2009).
   PubMed Web of Science ®Google Scholar
• Morbach H, Hedrich CM, Beer M, Girschick HJ. Autoinflammatory bone disorders. Clin. Immunol. 147(3), 185–196 (2013).
   Google Scholar
• Girschick HJ, Huppertz HI, Harmsen D, Krauspe R, Muller-Hermelink HK, Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum. Pathol. 30, 59 (1999).
   PubMed Web of Science ®Google Scholar
• Girschick HJ, Raab P, Surbaum S et al. Chronic non-bacterial osteomyelitis in children. Ann. Rheum. Dis. 64, 279 (2005).
   PubMed Web of Science ®Google Scholar
• Jansson A, Renner ED, Ramser J et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 46, 154 (2007).
   PubMed Web of Science ®Google Scholar
• Fritz J, Tzaribatchev N, Claussen CD, Carrino JA, Horger MS. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 252, 842 (2009).
   PubMed Web of Science ®Google Scholar
• Morbach H, Schneider P, Schwarz T et al. Comparison of magnetic resonance imaging and 99mTechnetium-labelled methylene diphosphonate bone scintigraphy in the initial assessment of chronic non-bacterial osteomyelitis of childhood and adolescents. Clin. Exp. Rheumatol. 30, 578 (2012).
   PubMed Web of Science ®Google Scholar
• Bousvaros A, Marcon M, Treem W et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig. Dis. Sci 44, 2500 (1999).
   PubMed Web of Science ®Google Scholar
• Huber AM, Lam PY, Duffy CM et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J. Pediatr. 141, 198 (2002).
   PubMed Web of Science ®Google Scholar
• Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine 68, 245 (2001).
   PubMed Web of Science ®Google Scholar
• Morbach H, Dick A, Beck C et al. Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants. Rheumatol. Int. 30, 617 (2010).
   Google Scholar
• Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr. Dermatol. 15, 435 (1998).
   PubMed Web of Science ®Google Scholar
• Tlougan BE, Podjasek JO, O'Haver J et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr. Dermatol. 26, 497 (2009).
   PubMed Web of Science ®Google Scholar
• Vittecoq O, Said LA, Michot C et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 43, 109 (2000).
   PubMed Web of Science ®Google Scholar
• Jansson AF, Muller TH, Gliera L et al. Clinical score for nonbacterial osteitis in children and adults. Arthritis Rheum. 60, 1152 (2009).
   PubMed Web of Science ®Google Scholar
• Jurik AG, Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skeletal Radiol. 26, 230 (1997).
   PubMed Web of Science ®Google Scholar
• Khanna G, Sato TS, Ferguson P. Imaging of chronic recurrent multifocal osteomyelitis. Radiographics 29, 1159 (2009).
   PubMed Web of Science ®Google Scholar
• Neubauer H, Evangelista L, Morbach H et al. Diffusion-weighted MRI of bone marrow oedema, soft tissue oedema and synovitis in paediatric patients: feasibility and initial experience. Pediatr. Rheumatol. Online. J. 10, 20 (2012).
   Google Scholar
• Schilling F, Kessler S. [Chronic recurrent multifocal osteomyelitis-- I. Review]. Klin. Padiatr. 213, 271 (2001).
   PubMedGoogle Scholar
• Hedrich CM, Tsokos GC. Bridging the gap between autoinflammation and autoimmunity. Clin. Immunol. (2013).
   Google Scholar
• Herlin T, Fiirgaard B, Bjerre M et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann. Rheum. Dis. 72, 410 (2013).
   PubMed Web of Science ®Google Scholar
• Majeed HA, Kalaawi M, Mohanty D et al. Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J. Pediatr. 115, 730 (1989).
   PubMed Web of Science ®Google Scholar
• Al-Mosawi ZS, Al-Saad K, Ijadi-Maghsoodi R, El-Shanti HI, Ferguson PJ. A splice site mutation confirms the role of LPIN2 in Majeed syndrome. Arthritis Rheum. 56, 960 (2007).
   PubMed Web of Science ®Google Scholar
• Ferguson PJ, Chen S, Tayeh MK et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet. 42, 551 (2005).
   PubMed Web of Science ®Google Scholar
• Donkor J, Zhang P, Wong S et al. A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin-1 and lipin-2. J. Biol. Chem. 284, 29968 (2009).
   Google Scholar
• Valdearcos M, Esquinas E, Meana C et al. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J. Biol. Chem. 287, 10894 (2012).
   PubMed Web of Science ®Google Scholar
• Marcuzzi A, Crovella S, Monasta L, Vecchi BL, Gattorno M, Frenkel J. Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. Curr. Pharm. Des. 18, 5746 (2012).
   Google Scholar
• Hanna N, Parfait B, Talaat IM, Vidaud M, Elsedfy HH. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome. Clin. Genet. 75, 568 (2009).
   Google Scholar
• Jafarov T, Ferimazova N, Reichenberger E. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Clin. Genet. 68, 190 (2005).
   Google Scholar
• van Capelle CI, Hogeman PH, van der Sijs-Bos CJ et al. Neurofibromatosis presenting with a cherubism phenotype. Eur. J. Pediatr. 166, 905 (2007).
   Google Scholar
• Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin. Proc. 72, 611 (1997).
   PubMed Web of Science ®Google Scholar
• Wise CA, Gillum JD, Seidman CE et al.. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum. Mol. Genet. 11, 961 (2002).
   PubMed Web of Science ®Google Scholar
• McDermott MF. A common pathway in periodic fever syndromes. Trends Immunol. 25, 457 (2004).
   Google Scholar
• Reddy S, Jia S, Geoffrey R et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N. Engl. J. Med. 360, 2438 (2009).
   PubMed Web of Science ®Google Scholar
• Chitu V, Ferguson PJ, de BR et al. Primed innate immunity leads to autoinflammatory disease in PSTPIP2-deficient cmo mice. Blood 114, 2497 (2009).
   PubMed Web of Science ®Google Scholar
• Ferguson PJ, Bing X, Vasef MA et al. A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38, 41 (2006).
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aksentijevich I, Galon J et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97, 133 (1999).
   PubMed Web of Science ®Google Scholar
• Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345 (1999).
   PubMed Web of Science ®Google Scholar
• Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu. Rev. Immunol. 20, 795 (2002).
   PubMed Web of Science ®Google Scholar
• Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309 (1997).
   PubMed Web of Science ®Google Scholar
• Tsuda E, Goto M, Mochizuki S et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234, 137 (1997).
   PubMed Web of Science ®Google Scholar
• Nakashima T, Takayanagi H. Osteoclasts and the immune system. J. Bone Miner. Metab. 27, 519 (2009).
   Google Scholar
• Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J. Clin. Immunol. 29, 555 (2009).
   PubMed Web of Science ®Google Scholar
• Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292 (2007).
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest 103, 1345 (1999).
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Okamoto K et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 203, 2673 (2006).
   PubMed Web of Science ®Google Scholar
• Hofmann SR, Schwarz T et al. Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. Clin. Immunol. 141, 317 (2011).
   PubMed Web of Science ®Google Scholar
• Hofmann SR, Morbach H, Schwarz T, Rosen-Wolff A, Girschick HJ, Hedrich CM. Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression. Clin. Immunol. 145, 69 (2012).
   PubMed Web of Science ®Google Scholar
• Cesar-Neto JB, Duarte PM, de Oliveira MC, Tambeli CH, Sallum EA, Nociti FH Jr. Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues. J. Periodontal Res. 42, 184 (2007).
   Web of Science ®Google Scholar
• Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 8, 4 (2007).
   PubMed Web of Science ®Google Scholar
• Mohamed SG, Sugiyama E, Shinoda K et al. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Bone 41, 592 (2007).
   Google Scholar
• Hofmann SR, Rosen-Wolff A, Tsokos GC, Hedrich CM. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin. Immunol. 143, 116 (2012).
   PubMed Web of Science ®Google Scholar
• Golla A, Jansson A, Ramser J et al. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur. J. Hum. Genet. 10, 217 (2002).
   PubMedGoogle Scholar
• Schilling F, Marker-Hermann E. [Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO]. Z. Rheumatol. 62, 527 (2003).
   PubMed Web of Science ®Google Scholar
• Byun JY, Lee GY, Choi HY, Myung KB, Choi YW. The expressions of TGF-beta(1) and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann. Dermatol. 23, 19 (2011).
   PubMed Web of Science ®Google Scholar
• Denning TL, Kim G, Kronenberg M. Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J. Immunol. 174, 7487 (2005).
   PubMed Web of Science ®Google Scholar
• Docke WD, Asadullah K, Belbe G et al. Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis. J. Leukoc. Biol. 85, 582 (2009).
   PubMedGoogle Scholar
• Glowacka E, Lewkowicz P, Rotsztejn H, Zalewska A. IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. Adv. Med. Sci 55, 254 (2010).
   Google Scholar
• Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 47, 185 (2010).
   PubMed Web of Science ®Google Scholar
• Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313 (2009).
   PubMed Web of Science ®Google Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263 (1993).
   PubMed Web of Science ®Google Scholar
• Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71 (2011).
   PubMed Web of Science ®Google Scholar
• Hamel J, Paul D, Gahr M, Hedrich CM. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol. Int. 32, 555 (2012).
   Google Scholar
• Beck C, Girschick HJ, Morbach H et al. Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence. Clin. Exp. Rheumatol. 29, 1040 (2011).
   Google Scholar
• Hurtado-Nedelec M, Chollet-Martin S, Chapeton D, Hugot JP, Hayem G, Gerard B. Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes. J. Rheumatol. 37, 401 (2010).
   PubMedGoogle Scholar
• Beck C, Morbach H, Beer M et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res. Ther. 12, R74 (2010).
   PubMed Web of Science ®Google Scholar
• Twilt M, Laxer RM. Clinical care of children with sterile bone inflammation. Curr. Opin. Rheumatol. 23, 424 (2011).
   PubMedGoogle Scholar
• Borzutzky A, Stern S, Reiff A et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics 130, e1190–e1197. (2012).
   PubMed Web of Science ®Google Scholar
• Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr. Rheumatol. Rep. 14, 130 (2012).
   PubMed Web of Science ®Google Scholar
• Hospach T, Langendoerfer M, von KT, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur. J. Pediatr. 169, 1105 (2010).
   PubMed Web of Science ®Google Scholar
• Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr. Rheumatol. Online. J. 7, 2 (2009).
   PubMedGoogle Scholar
• Morbach H, Stenzel M, Girschick HJ. Bisphosphonate treatment for patients with chronic nonbacterial osteomyelitis. Nat. Clin. Pract. Rheumatol. 4, 570 (2008).
   Google Scholar
• Simm PJ, Allen RC, Zacharin MR. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J. Pediatr. 152, 571 (2008).
   PubMed Web of Science ®Google Scholar